SMS Lifesciences India is currently trading at Rs. 365.80, up by 27.90 points or 8.26% from its previous closing of Rs. 337.90 on the BSE.
The scrip opened at Rs. 345.00 and has touched a high and low of Rs. 390.00 and Rs. 338.00 respectively. So far 543 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 549.65 on 25-Sep-2017 and a 52 week low of Rs. 134.85 on 17-Aug-2017.
Last one week high and low of the scrip stood at Rs. 390.00 and Rs. 300.00 respectively. The current market cap of the company is Rs. 108.84 crore.
The promoters holding in the company stood at 67.99%, while the Non-Institutions held 32.0 % stake in the company.
SMS Lifescience India has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for the inspection conducted in April 2018, at its manufacturing facility - Unit-I, located at Kazipally, Medak district in Hyderabad.
SMS Lifesciences India is engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1462.50 |
Dr. Reddys Lab | 5784.50 |
Cipla | 1451.25 |
Zydus Lifesciences | 1001.15 |
Lupin | 1587.90 |
View more.. |